MedTrace Logo

Directly Observed Antiretroviral Therapy Among Active Drug Users

NCT00367172 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 125

Last updated 2020-03-31

No results posted yet for this study

Summary

The goal of this randomized, controlled trial is to compare the effectiveness of a community-based program of providing supervised antiretroviral therapy to HIV-positive drug users, compared to having the patients take the medicines on their own.

Conditions

Interventions

BEHAVIORAL

Directly Administered Antiretroviral Therapy

Sponsors & Collaborators

  • Yale University

    lead OTHER

Principal Investigators

  • Frederick L Altice, M.D. · Yale AIDS Program

  • Gerald H Friedland · Yale AIDS Program

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-06-30
Primary Completion
2006-06-30
Completion
2006-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00367172 on ClinicalTrials.gov